These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cannabidiol Reduces Systemic Immune Activation in Experimental Acute Lung Injury. Hall S; Faridi S; Trivedi P; Castonguay M; Kelly M; Zhou J; Lehmann C Cannabis Cannabinoid Res; 2024 Oct; 9(5):1301-1311. PubMed ID: 37815809 [No Abstract] [Full Text] [Related]
4. A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome. Khodadadi H; Salles ÉL; Shin E; Jarrahi A; Costigliola V; Kumar P; Yu JC; Morgan JC; Hess DC; Vaibhav K; Dhandapani KM; Baban B J Cannabis Res; 2021 Oct; 3(1):45. PubMed ID: 34598736 [TBL] [Abstract][Full Text] [Related]
5. The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19. Azimi S; Saghafi F; Mohammadi MH; Moghimi MH; Akhavan SA; Khataminia M; Shirvani M; Sohrevardi SM; Jamialahmadi T; Sahebnasagh A; Sahebkar A Curr Pharm Des; 2023; 29(29):2291-2296. PubMed ID: 37818584 [TBL] [Abstract][Full Text] [Related]
6. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression. Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332 [TBL] [Abstract][Full Text] [Related]
7. Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders. Osborne AL; Solowij N; Babic I; Lum JS; Huang XF; Newell KA; Weston-Green K Brain Behav Immun; 2019 Oct; 81():574-587. PubMed ID: 31326506 [TBL] [Abstract][Full Text] [Related]
8. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794 [TBL] [Abstract][Full Text] [Related]
9. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia. Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911 [TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story? Ashtar Nakhaei N; Najarian A; Farzaei MH; Norooznezhad AH J Cannabis Res; 2022 Apr; 4(1):21. PubMed ID: 35414120 [TBL] [Abstract][Full Text] [Related]
11. Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells. Kozela E; Juknat A; Gao F; Kaushansky N; Coppola G; Vogel Z J Neuroinflammation; 2016 Jun; 13(1):136. PubMed ID: 27256343 [TBL] [Abstract][Full Text] [Related]
13. Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia. Jimenez Naranjo C; Osborne AL; Weston-Green K Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109640. PubMed ID: 31108177 [TBL] [Abstract][Full Text] [Related]
14. Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice. Gu B; Zhu M; Glass MR; Rougié M; Nikolova VD; Moy SS; Carney PR; Philpot BD J Clin Invest; 2019 Dec; 129(12):5462-5467. PubMed ID: 31503547 [TBL] [Abstract][Full Text] [Related]
15. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors. Sonego AB; Prado DS; Vale GT; Sepulveda-Diaz JE; Cunha TM; Tirapelli CR; Del Bel EA; Raisman-Vozari R; Guimarães FS Brain Behav Immun; 2018 Nov; 74():241-251. PubMed ID: 30217539 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol - studies in BV-2 microglia and encephalitogenic T cells. Juknat A; Kozela E; Kaushansky N; Mechoulam R; Vogel Z J Basic Clin Physiol Pharmacol; 2016 May; 27(3):289-96. PubMed ID: 26540221 [TBL] [Abstract][Full Text] [Related]
18. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis. Giacoppo S; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E Daru; 2015 Oct; 23():48. PubMed ID: 26489494 [TBL] [Abstract][Full Text] [Related]
19. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo. Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103 [TBL] [Abstract][Full Text] [Related]
20. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. Vuolo F; Abreu SC; Michels M; Xisto DG; Blanco NG; Hallak JE; Zuardi AW; Crippa JA; Reis C; Bahl M; Pizzichinni E; Maurici R; Pizzichinni MMM; Rocco PRM; Dal-Pizzol F Eur J Pharmacol; 2019 Jan; 843():251-259. PubMed ID: 30481497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]